Michael Tran, MD
Urology · Fridley, MNNPI 1568574630
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,800 of the $2,908 with a category attached, or 61.9%. Gyrus ACMI, Inc. accounts for 61.9% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $1,828, more than ten times the $51 reported in 2019.
Across 40 payments — averaging $72.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gyrus ACMI, Inc.$2K
- Coloplast$243
- Medtronic$204
- Intuitive Surgical$196
- Axonics, Inc.$120
- AbbVie$112
- plus $232 from 6 others
What the payments were for
- Consulting fees$1,80062%
- Food & beverage$1,10838%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gyrus ACMI, Inc. | 1 | $1,800 |
| Coloplast | 9 | $243 |
| Medtronic(2 entities) | 5 | $204 |
| Intuitive Surgical | 2 | $196 |
| Axonics, Inc. | 5 | $120 |
| AbbVie(2 entities) | 7 | $112 |
| Boston Scientific | 5 | $110 |
| Teleflex LLC | 2 | $64 |
| KARL Storz Endoscopy-america | 1 | $17 |
| Neotract Inc. | 1 | $15 |
| Urovant Sciences Inc | 1 | $13 |
| Palette Life Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,908 in reported general payments places this provider in the 70th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 156 | $126,814 |
| Finasteride | 713 | $12,987 |
| Tamsulosin Hcl | 693 | $11,169 |
| Trospium Chloride | 134 | $8,585 |
| Tolterodine Tartrate ErTolterodine Tartrate | 76 | $5,535 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 173 | $5,440 |
| Dutasteride | 80 | $2,826 |
| Oxybutynin Chloride ErOxybutynin Chloride | 102 | $2,402 |
| Methenamine Hippurate | 17 | $2,099 |
| Estradiol | 38 | $2,059 |
| Solifenacin Succinate | 19 | $1,487 |
| Potassium Citrate ErPotassium Citrate | 16 | $1,175 |
| Cephalexin | 164 | $724 |
| Oxybutynin Chloride | 24 | $461 |
| Desmopressin Acetate | 13 | $428 |
Paid to pharmacies, not to this prescriber.
Other urology in Fridley
- Gregory HansonFridley$7K
- Joseph AkornorFridley$5K
- David YangMankato$298K
- Steven BernsteinEdina$271K
- Ayman SoubraMinneapolis$204K
- Sean ElliottMinneapolis$163K
- Jonathan WarnerRochester$144K
- Steven SiegelWoodbury$140K
- Aaron MilbankWoodbury$97K
- Tobias KohlerRochester$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.